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This Month in the Journal
CAPN10 Gene and Type 2 Diabetes, by Song et al.
(p. 208)
There have been many follow-up studies (with mixed
results) to the ﬁrst report of an association between the
calpain-10 gene CAPN10 and type 2 diabetes (T2D) (see
Horikawa et al. reference in Song et al.). Overall, the
CAPN10-T2D association, if it is found at all, appears
to be modest. In the hope of generating a more concrete
conclusion regarding the role of CAPN10 in T2D, Song
et al. collected the data from all of these population-
and family-based association studies for use in a meta-
analysis. Although, individually, none of the previous
studies had sufﬁcient power to provide a robust estimate
of the effect of CAPN10 on T2D risk, the pooled popu-
lation-based data indicate that the G/G genotype at
UCSNP-43 confers modest susceptibility to T2D, with
an odds ratio of 1.19. The pooled family-based data have
little power to detect a modest genetic effect and do not
provide support for this association. Horikawa et al. also
reported that the 112/121 haplotype combination in
CAPN10 is associated with increased susceptibility to
T2D. A pooled analysis indicates that this association
may have been overestimated in subsequent underpow-
ered studies and that a signiﬁcant association with the
haplotype combination is not seen when these small stud-
ies are disregarded. In addition to the lack of power in
the individual studies, Song et al. suggest several other
reasons for difﬁculties in conﬁrming the CAPN10-T2D
association. These include the fact that population-speciﬁc
linkage disequilibrium patterns have been overlooked, the
presence of population stratiﬁcation, and the scarcity of
prospective study designs. Although no deﬁnitive conclu-
sion about the role of CAPN10 in risk of T2D can be
made yet, this study does make it possible to more crit-
ically evaluate the data at hand and to better plan future
studies in this area.
Selection and Human mtDNA Evolution, by Elson et
al. (p. 229)
When mtDNA is used to trace human evolution, the
assumption is made that divergence obeys a molecular
clock and that selection has been negligible. If these as-
sumptions were false, it would mean that our estimates
of the rate of mtDNA evolution—and therefore our dat-
ing of events on the basis of this technology—are in-
accurate. Some analyses of selection in mtDNAhave been
performed, largely with limited stretches of mtDNA.
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Since complete mtDNA coding-region sequences are now
becoming available, it was possible for Elson et al. to
do a more thorough analysis of selection in mtDNA, by
use of both gene-by-gene and whole-genome approaches.
Although the evidence for selection was not consistent
throughout their comparisons, the gene-by-gene analysis
of substitutions in protein-coding genes shows that sets
of older sequence changes have relatively fewer nonsy-
nonymous changes than do sets of younger sequence
changes, which is most simply explained by the action
of negative selection. Also supporting the existence of
mtDNA selection are differences between the observed
and predicted numbers of nonsynonymous changes in
the sequences. Additional work will be needed to de-
termine the exact consequences of these selective forces
on rates of mtDNA evolution.
ETHE1 Mutations in Ethylmalonic Encephalopathy, by
Tiranti et al. (p. 239)
The metabolic disorder ethylmalonic encephalopathy
(EE) is associated with developmental delay and death,
usually by age 10 years. The gastrointestinal system and
peripheral vessels are also involved, as indicated by
chronic diarrhea, acrocyanosis, and petechiae. Although
it is known that high levels of ethylmalonic acid in the
body ﬂuids and low cytochrome c oxidase activity in
skeletal muscle are features of EE, the underlying defect
in this disorder has remained a mystery—that is, until
Tiranti et al. did a linkage study and mapped the EE
locus to chromosome 19q13. Although 1100 genes were
present in the critical region, Tiranti et al. were able to
zero in on the causative gene, ETHE1, using an integra-
tive genomics approach. The features of EE led Tiranti
et al. to suspect the involvement of a protein involved
in mitochondrial metabolism, so they narrowed the list
of candidate genes on the basis of the similarity of their
expression proﬁles to those of known mitochondrial
genes. Sixteen mutations were found in a gene formerly
known as “HSCO,” in both families and singleton cases.
All mutations, even missense, led to a loss of detectable
protein. A series of fractionation and localization ex-
periments suggests that the ETHE1 protein is localized
to the mitochondrial matrix, a ﬁnding that contradicts
a previous report. Although the protein has high ho-
mology with glyoxalase II, no enzymatic activity could
be detected in isolated mitochondria. Further studies are
needed to clarify the role of this putative enzyme in
mitochondrial homeostasis.
Am. J. Hum. Genet. 74:i–ii, 2004
ii
Bias in Conventional Linkage Analysis, by Schork and
Greenwood (p. 306)
Schork and Greenwood have identiﬁed a potentially se-
rious bias in nonparametric linkage (NPL) analysis meth-
ods that may be partly responsible for the difﬁculties in
using these methods to identify complex disease loci. This
bias toward the null hypothesis of no linkage ariseswhen
expected allele-sharing values are assigned to relativepairs
when marker information is uninformative; the amount
of bias varies on the basis of several aspects of the study
design, including the markers used, the sample size, and
the type of relative pairs. There are several potential ways
to lessen or eliminate this bias, such as removing unin-
formative relative pairs from the analysis, identifying ge-
nomic areas for which marker data are uninformative,
and using a denser genetic map to reduce uninforma-
tiveness; their usefulness should be studied further. For
now, Schork and Greenwood suggest that it may be bene-
ficial for researchers to re-evaluate their NPL resultswith
this bias in mind.
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